Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAB008 vs Avastin in Advanced ns-NSCLC
NCT05427305Phase 3Completed
- Sponsor
- TOT Biopharm
- Start
- Oct 2017
- Primary completion
- Mar 2020
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of pusintin in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by TOT Biopharm. Started Oct 2017; status: completed.
02
Drugs
pusintin
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT05427305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05427305.